We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

Pfizer stock traded down Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.Please watch the video at Investors.com - How To Buy Stocks: ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings ...

Pfizer, which reports financial results on Tuesday, has been under pressure from investors looking for an improved ...

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies ... generics and consumer health products to one focused on novel therapies.

Vaccines aren't the only products that could contribute to Pfizer's growth ... Although sales for this vaccine, marketed under the brand name SpikeVax, have deteriorated, it remains the biggest ...

Merger deal, which values Allergan at around $160 billion, allows Pfizer to locate its tax base in Ireland ...

The collaboration will include a portfolio of over 350 marketed products across a broad range ... and developed a very strong Pfizer brand. We are committed to delivering high quality medicines ...

Pfizer Inc. (NYSE:PFE – Get Free Report) shares traded up 2.9% on Wednesday following a stronger than expected earnings report. The company traded as high as $26.69 and last traded at $26.62.